FibroGen/ US31572Q8087 /
2024-07-26 9:59:50 PM | Chg. -0.10 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
1.15USD | -7.66% | 26,141 Turnover: 30,275.63 |
-Bid Size: - | -Ask Size: - | 1.31 | 1.06 |
GlobeNewswire
06-27
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire
06-18
FibroGen to Host Part II of Virtual KOL Investor Event Series to Review FG-3246 Development Program ...
GlobeNewswire
06-13
Xilio Therapeutics Appoints Aoife Brennan, M.D., and James Shannon, M.D., to its Board of Directors
GlobeNewswire
06-04
Bitterroot Bio Announces Appointment of Georgette Verdin as Chief People Officer and Sherwin Chen as...
GlobeNewswire
06-03
FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate FibroG...
GlobeNewswire
06-03
FibroGen Announces FDA Clearance of Investigational New Drug Application for FG-3165, a Galectin-9 T...
GlobeNewswire
05-23
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
04-24
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combinat...
GlobeNewswire
04-02
FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metast...
GlobeNewswire
02-26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
02-05
FibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program ...
GlobeNewswire
01-25
FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action ...
GlobeNewswire
2023-12-09
FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower ...
GlobeNewswire
2023-12-08
FibroGen/Astellas’ EVRENZO (roxadustat) Making In-Roads in European Market as In-Class Challenger, A...
GlobeNewswire
2023-11-30
Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers